Biomarkører for kardiovaskulær sygdom ved type 2-diabetes

Sara Kull Krogh, Andreas Andersen, Filip Krag Knop, Tina Vilsbøll

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Patients with Type 2 diabetes have an increased risk of cardiovascular disease. However, there exists a considerable heterogeneity in cardiovascular risk in this patient population. A heterogeneity, which may escape the predictive capability of established clinical risk scores. In this context, cardiovascular biomarkers are of significant interest as potential clinical tools to guide risk stratification of patients. Studies have identified N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T of particular potential in patients with Type 2 diabetes.

Bidragets oversatte titelBiomarkers of cardiovascular disease in patients with Type 2 diabetes
OriginalsprogDansk
ArtikelnummerV10180711
TidsskriftUgeskrift for Laeger
Vol/bind181
Antal sider6
ISSN0041-5782
StatusUdgivet - 2019

Emneord

  • Biomarkers/analysis
  • Cardiovascular Diseases/complications
  • Diabetes Mellitus, Type 2/complications
  • Humans
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Troponin T

Citationsformater